The International Union Against Cancer has launched a childhood cancer campaign to show that better awareness, early detection and appropriate treatment can make a difference in the developing world. Download full article
Upfront radiation improves progression-free survival and should be offered as an option to patients presenting with low-grade gliomas. Download full article
Lymphatic mapping and sentinel lymph node biopsy is a safe, accurate, and low-morbidity method for the pathologic staging of the regional nodal basin in primary cutaneous melanoma. Download full article
Selected press reports compiled by the ESO Cancer Media Centre Download full article
Late last year, US patients with advanced renal cell cancer gained access to an oral multi-kinase inhibitor, Nexavar (sorafinib) the first new drug approved for this disease in the last 10 years. Manufacturer Bayer [more]
It was while studying the benefits of offering patients a choice between radical and breast conserving therapy that Lesley Fallowfield first demonstrated the importance of doctor patient communication. Her findings haven’t always been welcome, but [more]
Herceptin may turn out to be the biggest advance in treating breast cancer since tamoxifen. But if we are to prevent soaring drugs bills eating up our health budgets or barring Europe’s poorer patients from [more]
Survival data from phase III trials can be very misleading because patients are not offered the best follow-up therapy argue Siegfried Seeber and Ada Braun in CancerWorld’s new Forum section. Emma Mason canvassed clinical trial [more]
Volker Diehl cultured the cells that characterise Hodgkin’s disease when everyone else had failed. He has high hopes that molecular medicine will throw light on many questions that remain unanswered. But he stresses that it [more]
In men with intermediate- to high-risk prostate cancer, radical prostatectomy has been shown to lower the risk of local or systemic progression, and cancer-specific and overall mortality, compared with watchful waiting. Download full article
Selected press reports complied by the ESO Cancer Media Centre Download full article
Advocates for early access to unproven treatments may believe they are helping patients, but their actions can put current patients at risk and deny future patients the knowledge they need to make evidence-based treatment decisions, [more]
Patients, doctors, academic researchers and the World Health Organization all want industry to be a lot more open about the drugs they are trialling. The industry is pleading commercial confidentiality. The two sides are locked [more]